AWARD. Eastern Visayas Media Without Borders recognizes Judge Georgina Uy Perez as 'Most Outstanding Regional Trial Court Judge on November 30, 2024.AWARD. Eastern Visayas Media Without Borders recognizes Judge Georgina Uy Perez as 'Most Outstanding Regional Trial Court Judge on November 30, 2024.

Frenchie Mae Cumpio case: Who is Tacloban City RTC Judge Georgina Perez?

2026/01/22 19:15

Tacloban City Regional Trial Court Branch 45 Judge Georgina Perez convicted 26-year-old Frenchie Mae Cumpio of terrorism financing, but acquitted her in the illegal possession of firearms and explosives case.

Lay worker Marielle Domequil, 28, also received the same sentence. The two have been in jail for nearly six years, following their arrest on February 7, 2020, at the office of alternative news outlet Eastern Vista in Tacloban City, together with rights advocates Alexander Philip Abinguna, Mira Legion, and Marissa Cabaljao. They are collectively referred to as the “Tacloban 5.”

Local and international groups condemned Cumpio’s conviction, saying it sends a “chilling message” to media, activists, and even ordinary people in the Philippines.

Then-president Rodrigo Duterte appointed Perez Tacloban City RTC judge in 2017. She was then promoted as vice executive judge in 2020 and later on as executive judge in 2022.  

In 2023, Perez flew to Australia as part of a Philippine judiciary delegation led by Supreme Court Chief Justice Alexander Gesmundo to participate in a legal counter-terrorism technical assistance study visit.

Judge Perez was recognized on November 30, 2024, as the “most outstanding regional trial court judge” by Eastern Visayas Media Without Borders. The group describes itself as “a convergence of media practitioners in Eastern Visayas” with a goal “to provide the public with timely and relevant news and information around the region and the country as well.”

Judge Georgina Uy Perez AWARD. Eastern Visayas Media Without Borders recognizes Judge Georgina Uy Perez as ‘Most Outstanding Regional Trial Court Judge on November 30, 2024.

The Integrated Bar of the Philippines – Leyte Chapter also recognized Perez as “Outstanding Member of the Judiciary” in 2025.

This is not the first time Perez has handed down a conviction in a terrorism financing case. On July 30, 2024, she ruled that Lucila Mabanan Gabane was “guilty beyond reasonable doubt of attempting to commit the crime of financing terrorism.”

Gabane was sentenced to an indeterminate prison term ranging from four months to over three years.

Perez’s husband, Roy Percival Perez, is a councilor in the municipality of Abuyog, Leyte. – Rappler.com

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26